Skeletal Dysplasias Reveal Genes of Importance in Skeletal Development and Structure

References

• Stelling, F.H. III. (1967). General affections of the skeletal system. Bone dysplasias, dystrophies and dysostoses. Pediatr. Clin. N. Am. 14:359–396.
   PubMed Web of Science ®Google Scholar
• Wynne-Davies, R. (1987). Skeletal dysplasias. Br. Med. J. (Clin. Res. Ed.) 295: 685–686.
   PubMed Web of Science ®Google Scholar
• Stoll, C., Dott, B., Roth, M.P., and Alembik, Y. (1989). Birth prevalence rates of skeletal dysplasias. Clin. Genet. 35:88–92.
   PubMed Web of Science ®Google Scholar
• Boyadijiev, S.A., and Jabs, E.W. (2000). Online Mendelian Inheritance in Man (OMIM) as a knowledgebase for human developmental disorders. Clin. Genet. 57:253–266.
   PubMed Web of Science ®Google Scholar
• Bankier, A., and Keith, C.G. (1989). POSSUM: The microcomputer laser- videodisk syndrome information system. Ophthal. Paediatr. Genet. 10: 51–52.
   PubMed Web of Science ®Google Scholar
• Guest, S.S., Evans, C.D., and Winter, R.M. (1999). The Online London Dysmorphology Database. Genet. Med. 1:207–212.
   PubMed Web of Science ®Google Scholar
• Dreyer, S.D., Zhou, G., and Lee, B. (1998). The long and the short of it: Developmental genetics of the skeletal dysplasias. Clin. Genet. 54:464–473.
   PubMed Web of Science ®Google Scholar
• Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C.,Rosewell, I.R., Stamp, G.W., Beddington, R.S., Mundlos, S., Olsen, B.R., Selby, P.B., and Owen, M.J. (1997). Cbfa1, a candidate gene for clei- docranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765–771.
   PubMed Web of Science ®Google Scholar
• Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G., Geoffroy, V., Amling, M., and Karsenty, G. (1999). A Cbfa1-dependent genetic path- way controls bone formation beyond embryonic development. Genes Dev. 13:1025–1036.
   PubMed Web of Science ®Google Scholar
• Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S.,Albright, S., Lindhout, D., Cole, W.G., Henn, W., Knoll, J.H., Owen, M.J., Mertelsmann, R., Zabel, B.U., and Olsen, B.R. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773–779.
   PubMed Web of Science ®Google Scholar
• Zhou, G., Chen, Y., Zhou, L., Thirunavukkarasu, K., Hecht, J., Chitayat, D., Gelb, B.D., Pirinen, S., Berry, S.A., Greenberg, C.R., Karsenty, G., and Lee, B. (1999). CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum. Mol. Genet. 8:2311–2316.
   PubMed Web of Science ®Google Scholar
• Schinke, T., and Karsenty, G. (1999). Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting el- ement in the mouse osteocalcin promoters. J. Biol. Chem. 274:30182–30189.
   PubMed Web of Science ®Google Scholar
• Hall, C.M., and Shaw, D.G. (1994). Computer diagnosis of skeletal dys- plasias and malformation syndromes. Acta Paediatr. Suppl. 406:73–76.
   PubMedGoogle Scholar
• Wright, E., Hargrave, M.R., Christiansen, J., Cooper, L., Kun, J., Evans, T., Gangadharan, U., Greenfield, A., and Koopman, P. (1995). The Sry- related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 9:15–20.
   PubMed Web of Science ®Google Scholar
• Lefebvre, V., Huang, W., Harley, V.R., Goodfellow, P.N., and de Crombrugghe, B. (1997). SOX9 is a potent activator of the chondrocyte- specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell Biol. 17:2336–2346.
   PubMed Web of Science ®Google Scholar
• Goodman, F.R., and Scambler, P.J. (2001). Human HOX gene mutations. Clin. Genet. 59:1–11.
   PubMed Web of Science ®Google Scholar
• Dreyer, S.D., Zhou, G., Baldini, A., Winterpacht, A., Zabel, B., Cole, W., Johnson, R.L., and Lee, B. (1998). Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat. Genet. 19:47–50.
   PubMed Web of Science ®Google Scholar
• Passos-Bueno, M.R., Wilcox, W.R., Jabs, E.W., Sertie, A.L., Alonso, L.G., and Kitoh, H. (1999). Clinical spectrum of fibroblast growth factor receptor mutations. Hum. Mutat. 14:115–125.
   PubMed Web of Science ®Google Scholar
• Vajo, Z., Francomano, C.A., and Wilkin, D.J. (2000). The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynosto- sis, and Crouzon syndrome with acanthosis nigricans. Endocr. Rev. 21: 23–39.
   PubMed Web of Science ®Google Scholar
• Dalgleish, R. (1997). The human type I collagen mutation database. Nucleic Acids Res. 25:181–187.
   PubMed Web of Science ®Google Scholar
• Nagase, T., Nagase, M., Hirose, S., and Ohmori, K. (2000). Crouzon syn- drome with acanthosis nigricans: Case report and mutational analysis. Cleft Palate Craniofac. J. 37:78–82.
   Google Scholar
• Sibley, K., Stern, P., and Knowles, M.A. (2001). Frequency of fibrob- last growth factor receptor 3 mutations in sporadic tumours. Oncogene 20:4416–4418.
   PubMed Web of Science ®Google Scholar
• Kastrinakis, N.G., Gorgoulis, V.G., Foukas, P.G., Dimopoulos, M.A., and Kittas, C. (2000). Molecular aspects of multiple myeloma. Ann. Oncol. 11:1217–1228.
   PubMed Web of Science ®Google Scholar
• Schipani, E., Kruse, K., and Juppner, H. (1995). A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodyspla- sia. Science 268:98–100.
   PubMed Web of Science ®Google Scholar
• Zhang, P., Jobert, A.S., Couvineau, A., and Silve, C. (1998). A ho- mozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J. Clin. Endocr. Metab. 83:3365–3368.
   PubMed Web of Science ®Google Scholar
• Weil, D., D’Alessio, M., Ramirez, F., de Wet, W., Cole, W.G., Chan, D., and Bateman, J.F. (1989). A base substitution in the exon of a collagen gene causes alternative splicing and generates a structurally abnormal polypeptide in a patient with Ehlers-Danlos syndrome type VII. EMBO J. 8:1705–1710.
   PubMed Web of Science ®Google Scholar
• Nuytinck, L., Freund, M., Lagae, L., Pierard, G.E., Hermanns-Le, T., and De Paepe, A. (2000). Classical Ehlers-Danlos syndrome caused by a mu- tation in type I collagen. Am. J. Hum. Genet. 66:1398–1402.
   PubMed Web of Science ®Google Scholar
• Wenstrup, R.J., Langland, G.T., Willing, M.C., D’Souza, V.N., and Cole,W.G. (1996). A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum. Mol. Genet. 5:1733–1736.
   PubMed Web of Science ®Google Scholar
• Michalickova, K., Susic, M., Willing, M.C., Wenstrup, R.J., and Cole,W.G. (1998). Mutations of the alpha 2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. Hum. Mol. Genet. 7:249–255.
   PubMed Web of Science ®Google Scholar
• Burch, G.H., Gong, Y., Liu, W., Dettman, R.W., Curry, C.J., Smith, L., Miller, W.L., and Bristow, J. (1997). Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genet. 17:104–108.
   PubMed Web of Science ®Google Scholar
• Nurminskaya, M.V., and Birk, D.E. (1998). Differential expression of genes associated with collagen fibril growth in the chicken tendon: Iden- tification of structural and regulatory genes by subtractive hybridization. Arch. Biochem. Biophys. 350:1–9.
   PubMed Web of Science ®Google Scholar
• Unger, S.L., Briggs, M.D., Holden, P., Zabel, B., Ala-Kokko, L., Paassilta,P., Lohiniva, J., Rimoin, D.L., Lachman, R.S., and Cohn, D.H. (2001). Multiple epiphyseal dysplasia: Radiographic abnormalities correlated with genotype. Pediatr. Radiol. 31:10–18.
   PubMed Web of Science ®Google Scholar
• Li, Q.Y., Lennon, G.G., and Brook, J.D. (1996). The identification of exons from the MED/PSACH region of human chromosome 19. Genomics 32:218–224.
   PubMed Web of Science ®Google Scholar
• Muragaki, Y., Mariman, E.C., van Beersum, S.E., Perala, M., van Mourik, J.B., Warman, M.L., Olsen, B.R., and Hamel, B.C. (1996). A mutation in the gene encoding the alpha 2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nat. Genet. 12:103–105.
   PubMed Web of Science ®Google Scholar
• Paassilta, P., Lohiniva, J., Annunen, S., Bonaventure, J., Le Merrer, M., Pai, L., and Ala-Kokko, L. (1999). COL9A3: A third locus for multiple epiphyseal dysplasia. Am. J. Hum. Genet. 64:1036–1044.
   PubMed Web of Science ®Google Scholar
• Czarny-Ratajczak, M., Lohiniva, J., Rogala, P., Kozlowski, K., Perala, M., Carter, L., Spector, T.D., Kolodziej, L., Seppanen, U., Glazar, R., Krolewski, J., Latos-Bielenska, A., and Ala-Kokko, L. (2001). A mutation in col9a1 causes multiple epiphyseal dysplasia: Further evidence for locus heterogeneity. Am. J. Hum. Genet. 69:969–980.
   PubMed Web of Science ®Google Scholar
• Chapman, K.L., Mortier, G.R., Chapman, K., Loughlin, J., Grant, M.E., and Briggs, M.D. (2001). Mutations in the region encoding the von Wille- brand factor A domain of matrilin-3 are associated with multiple epiphy- seal dysplasia. Nat. Genet. 28:393–396.
   PubMed Web of Science ®Google Scholar
• Hrabe de Angelis, M., and Strivens, M. (2001). Large-scale production of mouse phenotypes: The search for animal models for inherited diseases in humans. Brief Bioinf. 2:170–180.
   PubMedGoogle Scholar
• Walter, G., Bussow, K., Cahill, D., Lueking, A., and Lehrach, H. (2000). Protein arrays for gene expression and molecular interaction screening. Curr. Opin. Microbiol. 3:298–302.
   PubMed Web of Science ®Google Scholar
• Sillence, D.O., Senn, A., and Danks, D.M. (1979). Genetic heterogeneity in osteogenesis imperfecta. J. Med. Genet. 16:101–116.
   PubMed Web of Science ®Google Scholar